{"timestamp": 1771594790.0819113, "value": {"ticker": "PPCB", "company_name": "Propanc Biopharma, Inc.", "short_name": "Propanc Biopharma, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "Australia", "market_cap": 3058972, "float_shares": 5006914, "shares_outstanding": 15091133, "short_ratio": 0.67, "short_percent_of_float": 0.0591, "shares_short": 398642, "shares_short_prior": 231114, "insider_percent_held": 0.62478, "institution_percent_held": 0.00798, "total_cash": 602737, "total_debt": 695068, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 4.84, "current_ratio": 2.453, "book_value": 1.198, "price_to_book": 0.16919868, "operating_cashflow": -2108720, "free_cashflow": 12800931, "price": 0.2027, "52w_high": 11.0, "52w_low": 0.1555, "avg_volume": 1225063, "avg_volume_10d": 5454310, "full_time_employees": 1, "audit_risk": 0, "overall_risk": 0}}